Cellosaurus cell line NCC-CS1-C1 (CVCL

Cellosaurus NCC-CS1-C1 (CVCL_E6MD)

[Text][XML][JSON]

Cell line name

NCC-CS1-C1

Accession

CVCL_E6MD

Resource Identification Initiative

To cite this cell line use: NCC-CS1-C1 (RRID:CVCL_E6MD)

Comments

Part of: NCC sarcoma cell line panel.
Population: Japanese.
Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
Doubling time: 31 hours (PubMed=39645627).
Omics: Genomics; Whole exome sequencing.
Omics: Phenotyping; Drug screening.
Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.

Sequence variations

Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Ser (c.394C>A); ClinVar=VCV000375893; Zygosity=Unspecified (PubMed=39645627).

Disease

Chondrosarcoma, grade 3 (NCIt: C121871)
Chondrosarcoma (ORDO: Orphanet_55880)

Species of origin

Homo sapiens (Human) (NCBI Taxonomy: 9606)

Sex of cell

Male

Age at sampling

54Y

Category

Cancer cell line

STR profile

Source(s): PubMed=39645627

Markers:

Amelogenin	X,Y
CSF1PO	12
D5S818	8
D7S820	8,11
D13S317	9
D16S539	9,10
D21S11	29
TH01	9
TPOX	8,9
vWA	14,18

Publications

PubMed=39645627; DOI=10.1007/s13577-024-01152-0
Rei Noguchi, Takuya Ono, Julia Osaki, Yuki Adachi, Shuhei Iwata, Yomogi Shiota, Kazuyoshi Yanagihara, Shogo Nishino, Takaya Funada, Koichi Ogura, Akihiko Yoshida ...Show all 13 authors... , Akira Kawai, Tadashi Kondo; Show fewer authors
Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1.
Hum. Cell 38:28.1-28.10(2025)

Entry history

Entry creation

10-Apr-2025

Last entry update

10-Apr-2025

Version number